Literature DB >> 27826615

Roles of programmed cell death protein 5 in inflammation and cancer (Review).

Wei Wang1, Xiao-Wen Song1, Cheng-Hai Zhao1.   

Abstract

PDCD5 (programmed cell death 5) is an apoptosis related gene cloned in 1999 from a human leukemic cell line. PDCD5 protein containing 125 amino acid (aa) residues sharing significant homology to the corresponding proteins of species. Decreased expression of PDCD5 has been found in many human tumors, including breast, gastric cancer, astrocytic glioma, chronic myelogenous leukemia and hepatocellular carcinoma. In recent years, increased number of studies have shown the functions and mechanisms of PDCD5 protein in cancer cells, such as paraptosis, cell cycle and immunoregulation. In the present review, we provide a comprehensive review on the role of PDCD5 in cancer tissues and cells. This review summarizes the recent studies of the roles of PDCD5 in inflammation and cancer. We mainly focus on discoveries related to molecular mechanisms of PDCD5 protein. We also discuss some discrepancies between the current studies. Overall, the current available data will open new perspectives for a better understanding of PDCD5 in cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27826615     DOI: 10.3892/ijo.2016.3706

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  PDCD5 regulates cell proliferation, cell cycle progression and apoptosis.

Authors:  Penghui Li; Hongxin Fei; Lihong Wang; Huiyu Xu; Haiyan Zhang; Lihong Zheng
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

2.  PDCD5 inhibits progression of renal cell carcinoma by promoting T cell immunity: with the involvement of the HDAC3/microRNA-195-5p/SGK1.

Authors:  Shu-Cheng Liu; Li-Bo Chen; Ping-Feng Chen; Meng-Long Huang; Tian-Pei Liu; Jun Peng; Xin-Sheng Lu
Journal:  Clin Epigenetics       Date:  2022-10-20       Impact factor: 7.259

3.  Club cell-specific role of programmed cell death 5 in pulmonary fibrosis.

Authors:  Soo-Yeon Park; Jung Yeon Hong; Soo Yeon Lee; Seung-Hyun Lee; Mi Jeong Kim; Soo Yeon Kim; Kyung Won Kim; Hyo Sup Shim; Moo Suk Park; Chun Geun Lee; Jack A Elias; Myung Hyun Sohn; Ho-Geun Yoon
Journal:  Nat Commun       Date:  2021-05-19       Impact factor: 14.919

4.  MicroRNA-766 Promotes The Proliferation, Migration And Invasion, And Inhibits The Apoptosis Of Cutaneous Squamous Cell Carcinoma Cells By Targeting PDCD5.

Authors:  Pengyu Liu; Liang Shi; Yan Ding; Jiaxi Luan; Xiaojun Shan; Qinghua Li; Shuhua Zhang
Journal:  Onco Targets Ther       Date:  2020-05-13       Impact factor: 4.147

5.  The Molecular Evolution and Functional Divergence of Lamprey Programmed Cell Death Genes.

Authors:  Xin Guan; Jiali Lu; Feng Sun; Qingwei Li; Yue Pang
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

6.  Efficacy of Camrelizumab in Advanced Non-Small-Cell Lung Cancer and Prognostic Analysis of Different PET/CT Features.

Authors:  Jinhai Zou; Chunying Li; Yu Han; Yu Xing; Yingying Zhan; Chao Zuo; Xinyue Ren; Rongge Xing; Nan Zhang
Journal:  J Oncol       Date:  2022-03-25       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.